Skip to main content
. 2017 Mar 24;20(1):82–90. doi: 10.4048/jbc.2017.20.1.82

Figure 1. Changes in mean left ventricular ejection fraction (LVEF) depending on dexrazoxane (DZR) administration over time. Only ADJ group showed significant decrease of LVEF than ADJ with DZR group (group×time interaction, F=8.122, p<0.001). F for group, time and group×time interaction.

Figure 1

ADJ=anthracycline-based adjuvant chemotherapy followed by trastuzumab.